SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Viking Therapeutics, Inc. (VKTX)

VKTX RSS Feed
Add VKTX Price Alert      Hide Sticky   Hide Intro
Moderator: greens12, BrazenBull
Search This Board: 
Last Post: 7/18/2017 1:55:35 PM - Followers: 26 - Board type: Free - Posts Today: 0

 

 

VK0612

Viking Therapeutics is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The Company’s lead clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, for the treatment of patients recovering from non-elective hip fracture surgery. The Company’s second program is focused on the development of first-in-class, selective, small molecule agonists of the thyroid receptor beta, or TRß, for adrenoleukodystrophy, or ALD, and lipid disorders such as hypercholesterolemia and non-alcoholic steatohepatitis, or NASH. Viking is also developing additional programs targeted at diabetes, metabolic diseases and anemia.
 

Overview

Pills

We have a portfolio of five drug candidates in clinical trials or preclinical studies

Our lead clinical program, VK5211, is a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in development for the treatment of patients recovering from non-elective hip fracture surgery. VK5211 is designed to produce the therapeutic benefits of testosterone in muscle and bone with improved safety, tolerability and patient acceptance. We have initiated a Phase 2 clinical trial with VK5211 in patients recovering from non-elective hip fracture surgery. For more information on this study please visit NCT02578095.

Our second pipeline program is focused on the development of novel small molecule agonists of the thyroid beta (TRb) receptor, VK2809 and VK0214. These novel TRb agonists are being developed for hypercholesterolemia and fatty liver disease and X-linked adrenoleukodystrophy, or X-ALD. We have initiated Phase 2 clinical development of VK 2809 in hypercholesterolemia and fatty liver disease. VK0214 is in preclinical development for X-ALD.

We are also developing VK0612, a first-in-class, orally available drug 

VKTX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VKTX News: Viking Therapeutics Completes Enrollment in Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture 07/12/2017 07:00:00 AM
VKTX News: Current Report Filing (8-k) 07/06/2017 08:11:19 AM
VKTX News: Viking Therapeutics Appoints Charles A. Rowland Jr. to Board of Directors 07/06/2017 08:00:00 AM
VKTX News: Confidential Treatment Order (ct Order) 06/27/2017 04:31:03 PM
VKTX News: Small Company Offering and Sale of Securities Without Registration (d) 06/22/2017 04:38:53 PM
PostSubject
#426   Nice to see volume consistently higher for longer ZeWaffleBaron 07/18/17 01:55:35 PM
#425   100 days long and strong #100 BrazenBull 07/18/17 12:42:44 AM
#424   "Some 63 percent of drugs in Phase I greens12 07/17/17 07:52:13 PM
#423   Thanks for another great honest analysis. Biotechs greens12 07/16/17 12:20:46 AM
#422   Tough question. Phase 2's on average are ZeWaffleBaron 07/15/17 11:22:41 PM
#421   What chances would you give positive results for BrazenBull 07/15/17 07:25:16 PM
#420   I will be in the same boat. I BrazenBull 07/14/17 06:11:31 AM
#419   100 days from now, give it take a ZeWaffleBaron 07/13/17 11:38:36 PM
#418   With Managements poor performance recently I have lost greens12 07/12/17 12:38:50 PM
#417   Brutal, these guys as slow as snails, Hiroko greens12 07/12/17 12:16:41 PM
#416   Conference call said they were asking for modified ZeWaffleBaron 07/12/17 09:08:03 AM
#415   Don't they keep putting back the time for bigjake 07/12/17 09:02:59 AM
#414   Checked my email. Looks like results in ZeWaffleBaron 07/12/17 07:20:45 AM
#413   Looking good today, volume picking up. Would be greens12 07/11/17 02:35:21 PM
#412   Volume this morning. Not a lot, but ZeWaffleBaron 07/11/17 11:29:23 AM
#411   No kidding, attraction is in the next 3-4 greens12 07/09/17 12:20:33 PM
#410   You're kidding me. Another P&D? What is the attraction? Crusen 07/08/17 05:08:31 PM
#409   New Guy on BOD has a lot of greens12 07/06/17 10:19:30 PM
#408   "With our clinical pipeline advancing toward key data BrazenBull 07/06/17 03:48:53 PM
#407   Viking Therapeutics Appoints Charles A. Rowland Jr. to greens12 07/06/17 11:17:10 AM
#406   Will be nice when this show gets a movinn! BrazenBull 07/05/17 03:11:37 PM
#405   An Inside Look At The Rally In Biotech greens12 06/30/17 12:41:37 PM
#404   Thanks for the reply, sounds good to me.Ok greens12 06/28/17 11:39:25 AM
#403   One addition- I am looking at two ZeWaffleBaron 06/28/17 02:09:19 AM
#402   Stock will gravitate near the recent offering price, ZeWaffleBaron 06/28/17 01:55:33 AM
#401   Hey Waffles, with the volume so high the greens12 06/28/17 12:48:01 AM
#400   The volume is good but for .5 Million greens12 06/27/17 02:32:38 AM
#399   always happy to see some volume BrazenBull 06/27/17 01:41:20 AM
#398   Thanks Waffles,I really appreciate your insight here. made greens12 06/24/17 01:09:19 PM
#397   It's all good buddy, we've all been at ZeWaffleBaron 06/24/17 12:54:44 PM
#396   So much riding on this I let my greens12 06/23/17 11:13:53 PM
#395   all good brother, was a tough week. I BrazenBull 06/23/17 11:06:14 PM
#394   wanted to say sorry to all on this greens12 06/23/17 10:53:11 PM
#393   Zacks research 7.00 valuation http://s1.q4cdn.com/460208960/files/News/2017/June-19-2017_VKTX_Baut greens12 06/22/17 02:19:05 PM
#392   bouncing off 1.00 support greens12 06/22/17 02:04:28 PM
#391   Greens lol! alx8967 06/21/17 07:13:26 PM
#390   The first person to be fired from VKTX greens12 06/20/17 11:58:13 PM
#389   so glad I did not buy any warrants...this greens12 06/20/17 11:36:59 PM
#388   Good for you you feel like its Christmas greens12 06/20/17 10:40:05 PM
#387   Totally understand your position and frustrations. If ZeWaffleBaron 06/20/17 08:20:11 PM
#386   when will you be convinced that news was greens12 06/20/17 08:01:58 PM
#385   Management is as bad as it gets,...they all greens12 06/20/17 07:46:08 PM
#384   Scary. Hold on tight boys. We could see alx8967 06/20/17 05:51:51 PM
#383   What the hell happened. BrazenBull 06/20/17 03:49:50 PM
#382   We cancelled the 2016 deal with Aspire, this BrazenBull 06/19/17 07:23:24 PM
#381   Thanks for the reply, yeah my concern was greens12 06/17/17 07:18:53 PM
#380   They don't say if the dosing is monitored/observed ZeWaffleBaron 06/17/17 06:47:39 PM
#379   Study says dosed once daily. It takes ZeWaffleBaron 06/17/17 06:40:51 PM
#378   Yes sir good play alx8967 06/17/17 02:28:21 PM
#377   My goal is to make money, but I greens12 06/17/17 01:54:48 AM
PostSubject